News & Disclosures

Official press releases, regulatory notifications, financial announcements, and corporate disclosures from VVT Med Inc. All material information is filed on SEDAR+ as required by applicable securities law.

Filter:
Corporate

VVT Med Announces Debt Settlement and Equity Incentive Grants to Strengthen Capital Structure

VVT Med will settle CAD$212,939.76 in vendor debt through the issuance of 586,096 common shares, subject to TSX Venture Exchange approval and a four-month statutory hold. The company also granted 688,773 stock options and 912,519 Restricted Share Units to directors, employees, and advisory board members, and confirmed the British Columbia Securities Commission revoked its management cease trade order on July 2, 2026.

Commercial

VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor

VVT Med established a Trial Distribution and Evaluation Agreement with Antilles Medical as exclusive distributor of ScleroSafe™ in the Dominican Republic, with an initial purchase order and a structured pathway toward a five-year partnership. The company also announced plans to close a second tranche of its private placement on or about July 20, 2026, with proceeds directed toward expanded global commercialization.

Regulatory

VVT Med Announces Positive Clinical Data for ScleroSafe® Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery

Peer-reviewed results show the ScleroSafe catheter-directed sclerotherapy system achieved 95% vein occlusion at 30 days with no serious adverse events across 30 patients at Holy Spirit Hospital in Mumbai. The publication validates the technology's efficacy as a non-thermal, non-tumescent treatment for varicose veins.

Commercial

VVT Med Signs Largest European Distribution Agreement to Date; Distributor Joins as Investor

VVT Med secured an exclusive five-year distribution partnership with Uber Ros S.p.A. covering Italy, Vatican City, and San Marino, representing approximately CAD $2.3 million in minimum purchase commitments. The distributor also joined the company's private placement financing, demonstrating strategic confidence in VVT Med's NT-NT technology platform.

Disclosure Notice: All material news affecting the Company is filed as a news release on SEDAR+ and disseminated to newswire services in accordance with TSXV continuous disclosure requirements. The list above may not be exhaustive; search SEDAR+ for the complete disclosure record.